10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
9.47
-0.06 (-0.63%)
At close: Jun 02, 2025, 3:59 PM
9.54
0.74%
Pre-market: Jun 03, 2025, 04:01 AM EDT

10x Genomics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Consumables Revenue 493.43M 479.55M 435.59M 418.74M 252.69M 206.88M
Consumables Revenue Growth +2.89% +10.09% +4.02% +65.72% +22.14% n/a
Instruments Revenue 92.72M 123.47M 8.43M 7.28M 6.03M 4.07M
Instruments Revenue Growth -24.91% +1365.53% +15.79% +20.62% +48.21% n/a
Service Revenue 24.64M 15.7M n/a n/a n/a n/a
Service Revenue Growth +56.90% n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Americas Revenue 347.76M 373.19M 46M 42.09M 24.51M 18.21M
Americas Revenue Growth -6.81% +711.22% +9.31% +71.73% +34.57% n/a
Americas, Excluding United States Revenue 13.45M 13.1M 59.56M 74.92M 41.74M 29.92M
Americas, Excluding United States Revenue Growth +2.64% -78.00% -20.51% +79.50% +39.51% n/a
Asia Pacific Revenue 103.26M 103.26M 117.07M 108.49M 73.27M 58M
Asia Pacific Revenue Growth 0.00% -11.80% +7.91% +48.08% +26.31% n/a
Asia-Pacific, Excluding China Revenue 45.96M 52.29M 284.99M 258.27M n/a n/a
Asia-Pacific, Excluding China Revenue Growth -12.12% -81.65% +10.34% n/a n/a n/a
China Revenue 57.3M 50.97M n/a n/a n/a n/a
China Revenue Growth +12.43% n/a n/a n/a n/a n/a
Emea Revenue 159.76M 142.28M n/a n/a n/a n/a
Emea Revenue Growth +12.29% n/a n/a n/a n/a n/a
United States Revenue 334.32M 360.09M n/a n/a n/a n/a
United States Revenue Growth -7.16% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue 89.73M 93.83M 81.7M 83.04M 84.67M 86.13M 82.42M 91.51M 83.28M 78.89M 73.4M 79.34M 66.67M 69.88M 62.08M 68.7M 56.9M 55.97M 51.55M 44.42M 50.39M 38.76M 32.61M 32.57M 26.89M 26.91M 19.11M 21.2M 20.96M
Selling, General, and Administrative Revenue Growth -4.37% +14.84% -1.61% -1.93% -1.68% +4.50% -9.94% +9.88% +5.57% +7.47% -7.48% +18.99% -4.59% +12.57% -9.65% +20.73% +1.66% +8.58% +16.06% -11.85% +30.01% +18.83% +0.13% +21.11% -0.05% +40.80% -9.86% +1.15% n/a
Research and Development Revenue 64.25M 66.97M 66.17M 62.92M 67.94M 55.55M 107.91M 71.46M 67.1M 63.61M 67.29M 70.69M 64.08M 61.88M 54.58M 53.4M 41.88M 39.7M 30.14M 27.54M 25.99M 27.89M 22.21M 18.03M 14.96M 13.08M 11.09M 11.44M 14.79M
Research and Development Revenue Growth -4.07% +1.20% +5.17% -7.39% +22.30% -48.52% +51.01% +6.50% +5.48% -5.46% -4.80% +10.31% +3.55% +13.38% +2.21% +27.50% +5.49% +31.72% +9.47% +5.94% -6.80% +25.58% +23.15% +20.51% +14.41% +18.00% -3.14% -22.62% n/a